Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CLN-049 |
Trade Name | |
Synonyms | CLN049|CLN 049 |
Drug Descriptions |
CLN-049 is a bispecific antibody that targets FLT3 and CD3, potentially inducing activation of CD4- and CD8-positive T cells and inhibiting tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2078). |
DrugClasses | CD3 Antibody 99 FLT3 Antibody 5 |
CAS Registry Number | NA |
NCIT ID | C185677 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CLN-049 | CLN-049 | 1 | 1 |